U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof

Patent 5990113 Issued on November 23, 1999. Estimated Expiration Date: Icon_subject December 16, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Diphenylpropanamines, compositions thereof and use thereof
Patent #: 4411904
Issued on: 10/25/1983
Inventor: Pattison

Aminobenzenesulfonic acid derivatives
Patent #: 5053409
Issued on: 10/01/1991
Inventor: Okushima, et al.

Polymorphic form of a tachykinin receptor antagonist
Patent #: 5457107
Issued on: 10/10/1995
Inventor: Kaufman

Benzimidazoles and imidazopyridines as central nervous system agents Patent #: 5486517
Issued on: 01/23/1996
Inventor: Downing, et al.

Inventors

Assignee

Application

No. 767062 filed on 12/16/1996

US Classes:

514/255.03, Carbocyclic ring bonded directly to the piperazine ring514/218, Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms540/575, The nitrogens are in the 1,4-positions of the hetero ring544/392, Phenyl or naphthyl bonded directly to ring nitrogen of the piperazine ring544/394, The other ring nitrogen has a substituent which includes chalcogen single bonded to acyclic carbon544/395The other ring nitrogen is unsubstituted or alkyl substituted only, or salt thereof

Examiners

Primary: Bernhardt, Emily

Attorney, Agent or Firm

Foreign Patent References

  • 0 390 654 EP. 10/12/1990
  • 2 503 611 DE. 08/12/1975
  • 2 126 598 GB. 03/12/1984

International Classes

A61K 031/495
A61K 031/55
C07D 295/096
C07D 243/08

Foreign Application Priority Data

1995-12-15 JP

Abstract

A monohydrate of an aminobenzenesulfonic acid derivative represented by the following formula (I), for example, 2-(1-piperazinyl)-5-methylbenzenesulfonic acid, is substantially free from weight change due to moisture absorption and can be weighed accurately in manufacturing a pharmaceutical composition for the treatment of heart diseases comprising said monohydrate. ##STR1##

Other References

  • Kitamura et al, Chemical Abstracts, vol. 111, No. 23519, 1989
  • Okujima et al., Chemical Abstracts, vol. 117, No. 21, Nov. 23, 1992, Abstract No. 212524h, p. 850 JP 04 139 12
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?